GlassScriptPhysician profile
Michael A Galin
NPI 1306819610
$4,685.91
in general payments reported to CMS, 2019-2025
20 companies · $824 in 2025
The $824 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,098 · 2020: $221 · 2021: $502 · 2022: $645 · 2023: $791 · 2024: $603 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,218.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,069.59 | 2021-2025 | Propel, Sinuva |
| Optinose US, INC. | $684.84 | 2019-2025 | |
| Intersect Ent, INC. | $653.24 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $400.86 | 2019-2025 | Dupixent |
| Acclarent, INC | $332.99 | 2019-2020 | |
| Genzyme Corporation | $290.01 | 2019-2024 | |
| Glaxosmithkline, LLC. | $257.73 | 2021-2025 | Nucala |
| Neurent Medical Limited | $250.72 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Aerin Medical INC. | $245.57 | 2019-2022 | |
| Stryker Corporation | $144.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $59.64 | 2023-2025 | Keytruda |
| Hologic Sales and Service, LLC | $48.44 | 2023 | Coolseal Generator |
| Ars Pharmaceuticals Operations, INC. | $48.17 | 2025 | Neffy |
| Medtronic USA, INC. | $40.89 | 2019 | |
| Smith+Nephew, INC. | $33.37 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $31.67 | 2021 | |
| Phadia US INC. | $27.42 | 2024 | Immunocap |
| Inspire Medical Systems, INC. | $25.39 | 2025 | Inspire |
| Alk-Abello, INC | $22.69 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.64 | 2023 | Hyqvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Galin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.